ArticleBone marrow transplantation2022

Allogeneic hematopoietic cell transplantation can overcome the adverse prognosis indicated by secondary-type mutations in de novo acute myeloid leukemia.

Ga-Young Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.